Bechter K (2020) The challenge of assessing mild neuroinflammation in severe mental disorders. Front Psychiatry 11:773

Article  PubMed  PubMed Central  Google Scholar 

Ellwardt E, Muthuraman M, Gonzalez-Escamilla G, Chirumamilla VC, Luessi F, Bittner S, Zipp F, S Groppa, Fleischer V (2022) Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation 19:119

Endres D, von Zedtwitz K, Matteit I, Bünger I, Foverskov-Rasmussen H, Runge K, Feige B, Schlump A, Maier S, Nickel K, Berger B, Schiele MA, Cunningham JL, Domschke K, Prüss H, Tebartz van Elst L (2022) Spectrum of novel anti-central nervous system autoantibodies in the cerebrospinal fluid of 119 patients with schizophreniform and affective disorders. Biol Psychiatry 92:261–274

Endres D, Hannibal L, Zaltenbach B, Schiele MA, Runge K, Nickel K, Berger B, Domschke K, Venhoff N, Prüss H, Tebartz van Elst L (2022) Case Report: Possible autoimmune obsessive-compulsive disorder with postpartum onset. Front Immunol 13:970448

Endres D, von Zedtwitz K, Urbach H, Dersch R, Runge K, Feige B, Nickel K, Schiele MA, Prüss H, Domschke K, Reisert M, Coenen VA (2022) Obsessive-compulsive symptoms in two patients with strategic basal ganglia lesions. Mol Psychiatry 28(2):528–531

Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL, ECNP Network Immuno-NeuroPsychiatry, Domschke K, Tebartz van Elst L, Schiele MA (2022) Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype? Transl Psychiatry 12:5

Endres D, Mertens L, Berger B, Reisert M, Runge K, Nickel K, Domschke K, Schiele MA, Urbach H, Venhoff N, Prüss H, Tebartz van Elst L (2022) Autoimmune obsessive-compulsive disorder with novel anti-basal ganglia antibodies. Psychother Psychosom 91:214–216

Endres D, Pankratz B, Robinson T, Pitsch K, Göbel T, Runge K, Schlump A, Nickel K, Reisert M, Urbach H, Voderholzer U, Venhoff N, Domschke K, Prüss H, Schiele MA, Tebartz van Elst L (2022) Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid. Mol Psychiatry 27:3926–3928

Foroughipour M, Behdani F, Hebrani P, Marvast MN, Esmatinia F, Akhavanrezayat A (2012) Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: a cross-sectional study. J Res Med Sci 6

Khatri IA, Aljwair S, Alammar H, Altariq A, Masud N, Al Malik Y, Kojan S (2021) Social anxiety and obsessive-compulsive disorder are common among persons with multiple sclerosis at king abdulaziz medical city. Riyadh Cureus 13(2):e13619

PubMed  Google Scholar 

Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler J 13:67–72

Article  CAS  Google Scholar 

Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, Aziat F, Wishart DS (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4:38

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187

Article  CAS  PubMed  Google Scholar 

Robbins TW, Vaghi MM, Banca P (2019) Obsessive-compulsive disorder: puzzles and prospects. Neuron 102:27–47

Article  CAS  PubMed  Google Scholar 

Runge K, Reisert M, Feige B, Nickel K, Urbach H, Venhoff N, Tzschach A, Schiele MA, Hannibal L, Prüss H, Domschke K, Tebartz van Elst L, Endres D (2023) Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results. Transl Psychiatry 13:83

San Hernandez AM, Singh C, Valero DJ, Nisar J, Trujillo Ramirez JI, Kothari KK, Isola S, Gordon DK (2020) Multiple sclerosis and serotonin: potential therapeutic applications. Cureus 12(11):e11293

PubMed  PubMed Central  Google Scholar 

Sepehrinezhad A, Shahbazi A, Bozorgmehr A, Kateb B, Yamamoto V, Negah SS (2022) STAT3 and NTRK2 genes predicted by the bioinformatics approach may play important roles in the pathogenesis of multiple sclerosis and obsessive-compulsive disorder. J Pers Med 12:1043

Article  PubMed  PubMed Central  Google Scholar 

Shephard E, Stern ER, van den Heuvel OA, Costa DLC, Batistuzzo MC, Godoy PBG, Lopes AC, Brunoni AR, Hoexter MQ, Shavitt RG, Reddy YCJ, Lochner C, Stein DJ, Simpson HB, Miguel EC (2021) Toward a neurocircuit-based taxonomy to guide treatment of obsessive–compulsive disorder. Mol Psychiatry 26:4583–4604

Article  PubMed  PubMed Central  Google Scholar 

Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, van den Heuvel OA, Simpson HB (2019) Obsessive-compulsive disorder. Nat Rev Dis Primer 5:52

Article  Google Scholar 

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173

Article  PubMed  Google Scholar 

Tinelli E, Francia A, Quartuccio EM, Morreale M, Contessa GM, Pascucci S, Sbardella E, Pozzilli C, Pantano P (2013) Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis. Am J Neuroradiol 34:305–309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uguz F, Akpinar Z, Ozkan I, Tokgoz S (2008) Mood and anxiety disorders in patients with multiple sclerosis. Int J Psychiatry Clin Pract 12:19–24

Article  PubMed  Google Scholar 

Voderholzer U, Favreau M, Rubart A, Staniloiu A, Wahl-Kordon A, Zurowski B, Kathmann N (2022) Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders. Nervenarzt 93:678–687

Article  PubMed  Google Scholar